The first five years of a child's life are crucial when it comes to preventing obesity in the future, according to researchers.Experts in the Netherlands found body mass index (BMI) at age six is a ...

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications. Clinical ...

Weight-loss injections, or GLP-1 receptor agonists, could nearly halve the risk of obesity-related cancers, a new study finds ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...

What if your toddler's chubby belly wasn't just "baby fat" that would disappear, but an early warning sign for serious health ...

A weekly dose of semaglutide, a drug used to manage diabetes and weight loss, was effective in 63% of patients at treating a ...

For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is ...

At the core of the “Make America Healthy Again” movement is a fatal contradiction. On the surface, it purports to favor the ...

Obesity before 30 almost doubles risk of dying young - Experts stressed the study was a ‘wake-up call’ that obesity can ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

The best metric is not weight, but a particularly toxic kind of fat.

Medications like semaglutide and liraglutide may help to reduce the risk for heart attacks, strokes, and other major adverse cardiovascular events (MACE) as well as death in adults with obesity and ...